Distal pankreatektomide solid psödopapiller tümör ve insulinoma birlikteliği
Multipl Endokrin Neoplazi Tip 1 otozomal dominant geçişli nadir bir genetik hastalık olup pankreas, paratiroid ve anterior pitüiter tümörleri ile karakterizedir. Pankreasın adacık hücre tümörleri daha az sıklıkta görülmekte olup bu tümörler içerisinde gastrinoma ve insulinoma daha çok ortaya çıkan tümörlerdir. Solid Psödopapiller Tümör pankreasın diğer bir nadir tümörü olup erken yaşta kadın hastalarda ortaya çıkan sıklıkla benign bir neoplazidir. Distal pankreatektomili, MEN 1 sendromu olan 16 yaşında erkek hastada eş zamanlı görülen solid psödopapiller neoplazi ve insulinoma olgusunu sunuyoruz. Hastanın nöbet şikayetleri mevcut olup acil servise başvurduğunda yüksek insülin düzeyine bağlı olarak hipoglisemi saptandı. Tanısal çalışmalar sırasında pankreas korpusunda multipl lezyonlar saptandı. Ailede, erkek kardeşinde asemptomatik paratiroid adenomu görüldü. Hastaya distal pankreatektomi uygulandı. Makroskopik incelemede bir neoplazi proksimal cerrahi sınıra yakın diğeri distal pankreas yerleşimli iki adet neoplazi bulundu. Histomorfolojik ve immünohistokimyasal değerlendirmede proksimaldeki lezyonun solid psödopapiller neoplazi, distaldeki lezyonun fonksiyonel nöroendokrin tümör (insulinoma) olduğu dikkati çekti.
Solid pseudopapillary tumor and insulinoma in distal pancreatectomy
Multiple endocrine neoplasia type 1 (MEN 1) is a rare autosomal dominant inherited endocrine disease characterized by pancreatic, parathyroid, and anterior pituitary tumours. Pancreatic islet tumours occur less frequently, among them gastrinomas and insulinomas are the most prevalent. A solid pseudopapillary neoplasm (SPN) is another extremely rare tumour of the pancreas that frequently occurs in young females and is mostly benign. We report a case of a 16-year-old male MEN 1 syndrome with insulinoma and solid pseudopapillary neoplasm in distal pancreatectomy. The patient presented with seizures. When admitted to the emergency room, hypoglisemia has been detected due to the high levels of insulin. Multiple lesions have been observed in the corpus of the pancreas during the diagnostic work-up. According to the parathyroid scintigraphy, an adenoma has been detected. In the family, an asymptomatic parathyroid adenoma has also been seen in his brother. Distal pancreatectomy has been performed. In the gross examination, one neoplasm close to the proximal margin, one in the distal part of the pancreas have been found. The histomorphological and immunohistochemical evaluation revealed the proximal neoplasm as solid pseudopapillary neoplasm and the distal one as functioning neuroendocrine tumor (insulinoma).
___
- 1. Yu PF, Hu ZH, Wang XB, Guo JM, Cheng XD,
Zhang YL et al. Solid pseudopapillary tumor of the
pancreas: a review of 553 cases in Chinese literature.
World J Gastroenterol. 2010;16:1209-14.
- 2. Kloppel G, Solcia E, Longnecker DS, Capella C,
Sobin-Leslie H. International Histological
Classification of Tumours. New York, Springer,
1996.
- 3. Papavramidis T, Papavramidis S. Solid
pseudopapillary tumors of the pancreas: review of
718 patients reported in English literature. J Am Coll
Surg. 2005;200:965-72.
- 4. Franko J, Feng W, Yip L, Genovese E, Moser AJ.
Non-functional neuroendocrine carcinoma of the
pancreas: incidence, tumor biology, and outcomes in
2,158 patients. J Gastrointest Surg. 2010;14:541-8.
- 5. Klimstra DS, Arnold R, Capella C. Neuroendocrine
neoplasms of the pancreas. . In: WHO Classification
of Tumours of the Digestive System (Eds FT Bosman, F Carneiro, RH Hruban, ND Theise):322-6.
Lyon, IARC Press, 2010.
- 6. Verbeke CS. Endocrine tumours of the pancreas.
Histopathology. 2010;56:669-82.
- 7. Capelli P, Martignoni G, Pedica F, Falconi M,
Antonello D, Malpeli G et al. Endocrine neoplasms
of the pancreas: pathologic and genetic features.
Arch Pathol Lab Med. 2009;133:350-64.
- 8. Burdan F, Mocarska A, Guz E, Paluszkiewicz P,
Terlecki P, Patyra K et al. Solid-pseudopapillary
neoplasm of the pancreas - comparisons between
magnetic resonance and histological findings. Pol J
Pathol. 2013;64:216-23.
- 9. Goh BK, Tan YM, Cheow PC, Chung AY, Chow
PK, Wong WK et al. Solid pseudopapillary
neoplasms of the pancreas: an updated experience. J
Surg Oncol. 2007;95:640-4.
- 10. Reddy S, Cameron JL, Scudiere J, Hruban RH,
Fishman EK, Ahuja N et al. Surgical management of
solid-pseudopapillary neoplasms of the pancreas
(Franz or Hamoudi tumors): a large singleinstitutional
series. J Am Coll Surg. 2009;208:950-7;
discussion 957-959.
- 11. Vassos N, Agaimy A, Klein P, Hohenberger W,
Croner RS. Solid-pseudopapillary neoplasm (SPN) of
the pancreas: Case series and literature review on an
enigmatic entity. Int J Clin Exp Pathol. 2013;6:1051-
9.
- 12. Kamat RN, Naik LD, Joshi RM, Amrapurkar AD,
Shetty TS. Solid pseudopapillary tumor of the
pancreas. Indian J Pathol Microbiol. 2008; 51:271-3.
- 13. Iglesias P, Diez JJ. Management of endocrine disease:
a clinical update on tumor-induced hypoglycemia.
Eur J Endocrinol. 2014;170: R147-157.
- 14. Cryer PE, Axelrod L, Grossman AB, Heller SR,
Montori VM, Seaquist ER. Service FJ, Endocrine S.
Evaluation and management of adult hypoglycemic
disorders: an Endocrine Society Clinical Practice
Guideline. J Clin Endocrinol Metab. 2009;94:709-28.
- 15. Placzkowski KA, Vella A, Thompson GB, Grant CS,
Reading CC, Charboneau JW. Secular trends in the
presentation and management of functioning
insulinoma at the Mayo Clinic 1987-2007. J Clin
Endocrinol Metab. 2009;94:1069-73.
- 16. Thakker RV, Newey PJ, Walls GV, Bilezikian J,
Dralle H, Ebeling PR. Clinical practice guidelines for
multiple endocrine neoplasia type 1 (MEN1). J Clin
Endocrinol Metab. 2012;97:2990-3011.
- 17. Machens A, Schaaf L, Karges W, Frank-Raue K,
Bartsch DK, Rothmund M. Age-related penetrance
of endocrine tumours in multiple endocrine
neoplasia type 1 (MEN1): A multicentre study of 258
gene carriers. Clin Endocrinol. (Oxf). 2007;67:613-
22.
- 18. Service FJ, McMahon MM, O'Brien PC, Ballard DJ.
Functioning insulinoma--incidence, recurrence, and
long-term survival of patients: a 60-year study. Mayo
Clin Proc. 1991;66:711-9.
- 19. Marini F, Falchetti A, Del Monte F, Carbonell Sala S,
Gozzini A, Luzi E et al. Multiple endocrine neoplasia
type 1. Orphanet J Rare Dis. 2006;1:38.
- 20. Thakker RV. Multiple endocrine neoplasia type 1
(MEN1) and type 4 (MEN4). Mol Cell Endocrinol.
2014;386:2-15.